KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response
Abstract Oxaliplatin resistance is a major challenge in the treatment of colorectal cancer (CRC). Many molecular targeted drugs for refractory CRC have been developed to solve CRC drug resistance, but their effectiveness and roles in the progression of CRC and oxaliplatin resistance remain unclear....
| المؤلفون الرئيسيون: | , , , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Nature Publishing Group
2022-04-01
|
| سلاسل: | Cell Death and Disease |
| الوصول للمادة أونلاين: | https://doi.org/10.1038/s41419-022-04773-1 |